Vitamin A Total Body Stores of Senegalese Children in Relation to Their Infectious Status
Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection in Senegal
1 other identifier
interventional
55
1 country
1
Brief Summary
Despite economic growth in developing countries, Sub-Saharan Africa still faces food insecurity malnutrition and infections. Micronutrient deficiency and infectious diseases still remain a public health problem and have a negative impact on health and the economy. They are both directly and indirectly responsible for children morbidity and mortality. Due to high level of children mortality (139‰) Vitamin A Supplementation (VAS) program was implemented in Senegal since 1999. A national representative study undertook in 2010 to have biological data on vitamin status and infections, showed that 24.4% of children aged 1-5 y were Vitamin A Deficiency (VAD) and 50.2% were infected. To address VAD issue, large scale oil fortification was launched by government and private industries also fortified bouillon cubes. Furthermore, home fortification is being initiated without evaluation of VAD control strategies existing in the country. In order to assess the impact of national VAD control strategies in Senegalese children, this study was designed to measure in subsample of rural children aged 3-5 y, the current vitamin A total body stores in relation to their infectious status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2017
CompletedStudy Start
First participant enrolled
February 3, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFebruary 26, 2019
February 1, 2019
6 months
January 24, 2017
February 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vitamin A status 1
Total body pool size vitamin A (mmol)
Within the coming 2 years
Secondary Outcomes (11)
Acute infection
Within the coming 2 years
Chronic infection
Within the coming 2 years
Iron status
Within the coming 2 years
Stunting
Within the coming 2 years
Wasting
Within the coming 2 years
- +6 more secondary outcomes
Study Arms (1)
Vitamin A supplementation
EXPERIMENTAL55 children will receive a Mega-dose of preformed Vitamin A as recommended by the Senegalese Ministry of Health
Interventions
200,000 IU of preformed vitamin A
Eligibility Criteria
You may qualify if:
- years, not planning to move from the study area for the duration of the study, and do not have severe illness at the time of enrollment.
You may not qualify if:
- severe anaemia, severe acute malnutrition, obesity or clinically defined severe illness, such as dehydration, severe diarrhoea or severe respiratory illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universite Cheikh Anta Diop
Dakar, Senegal
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Cornelia Loechl, PhD
International Atomic Energy Agency
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2017
First Posted
July 2, 2017
Study Start
February 3, 2017
Primary Completion
August 15, 2017
Study Completion
December 1, 2017
Last Updated
February 26, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share